article thumbnail

The Weekly Roundup: May 12-17

Dermatology Times

In case you missed it, this week we had news about roflumilast foam's efficacy in diverse hair types of seborrheic dermatitis, Lindus Health's new partnership to evaluate a benzoyl peroxide alternative, sonelokimab advancing to phase 3 for HS, and more.

article thumbnail

Done Deal: Organon Completes Acquisition of Dermavant

The Dermatology Digest

The FDA is reviewing a supplemental New Drug Application (sNDA) for tapinarof cream, 1%, as a potential treatment for atopic dermatitis (AD) in adults and children two years of age and older, with Prescription Drug User Fee Act (PDUFA) action expected in the fourth quarter of calendar year 2024.

article thumbnail

Almirall, Centre for Genomic Regulation Partner to Identify Molecular Pathways and Biomarkers for Atopic Dermatitis Treatments

Dermatology Times

The partnership is focused on exploring innovative therapeutic strategies to address AD.

article thumbnail

How to Treat Eyelid Dermatitis (Eczema)

US Dermatologt Partners

Dermatitis is an umbrella term that refers to a group of skin conditions that cause skin irritation, sensitivity, redness, and similar symptoms. As the name implies, eyelid dermatitis or eyelid eczema, is a form of dermatitis that impacts the upper or lower eyelid. What is Eyelid Dermatitis?

Eczema 41
article thumbnail

WHO Foundation, L’Oréal Groupe Join Forces to Improve Skin Health Worldwide

The Dermatology Digest

The WHO Foundation and the LOral Groupe , spearheaded by its Dermatological Beauty Division, are launching a four-year partnership to expand access to the treatment of skin conditions worldwide.

article thumbnail

And the Winners Are…PeDRA Announces 2023 Grant Recipients

The Dermatology Digest

2023 Childhood Eczema Challenge Grant – Supported in partnership with the National Eczema Association (NEA) Hassan Vahidnezhad, MSc, PhD of Children’s Hospital of Philadelphia, will conduct a project titled “ Genetic Landscape of Pediatric Patients with Monogenic Susceptibilities to Atopic Dermatitis.

article thumbnail

Clinique, Icahn School of Medicine at Mount Sinai Join Forces to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

The Dermatology Digest

Clinique has made a philanthropic commitment of $5 million over seven years for the advancement and evolution of allergy science through the partnership and founding of the Mount Sinai-Clinique Healthy Skin Dermatology Center. Years of chronic inflamed skin plays a role in premature aging.